ZEUS System vs qXR-CTR
AI Verdict
Choose ZEUS System if…
Choose ZEUS System if you require long-term, continuous cardiac monitoring to detect and characterize intermittent or asymptomatic arrhythmias, such as Atrial Fibrillation. This AI-powered solution is ideal for patients needing extended ECG data analysis from wearable biosensors to aid in early diagnosis and management of complex cardiac rhythm disorders.
View ZEUS System →Choose qXR-CTR if…
Choose qXR-CTR if you need a rapid, automated assessment of heart size from standard chest X-ray images to screen for potential heart failure risk. This AI-powered tool is best suited for scenarios where quick and objective measurement of the cardiothoracic ratio is crucial for initial cardiac evaluation in a radiology or emergency setting.
View qXR-CTR →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | ZEUS System | qXR-CTR |
|---|---|---|
| Pricing | Not disclosed | Unknown |
| Deployment | Cloud-based (AWS EC2 platform), no on-premise hardware. | Can be deployed on cloud or on-premise. The Qure.ai app receives DICOM studies via DICOM network protocol from medical systems (PACS/Modality) or can import DICOM from the local system. The received DICOM study is processed in Qure's cloud server, and AI-processed reports are displayed on the app. |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
ZEUS SystemThe ZEUS System integrates with Zio monitors, which are designed for patient simplicity and compliance, recording ECG data without patient interaction. Physicians can then access preliminary reports via the secure ZioSuite web portal, streamlining the workflow for long-term cardiac monitoring. This comprehensive approach to usability, encompassing both patient interaction and physician review, gives it an edge.
Clinical Value
ZEUS SystemThe ZEUS System offers continuous, long-term cardiac monitoring for up to 14 days, enabling early detection and characterization of arrhythmias like Atrial Fibrillation, including asymptomatic events. This proactive approach has significant potential for preventing serious cardiac events and improving patient outcomes. While qXR-CTR provides valuable automated measurements, ZEUS's continuous monitoring for dynamic conditions offers a broader clinical impact.
Pricing & Value
TieNeither Tool A nor Tool B publicly discloses their pricing information. Without any transparent pricing details or publicly available ROI studies, it is impossible to conduct a meaningful comparison of their pricing and overall value propositions.
Enterprise Readiness
qXR-CTRBoth tools demonstrate strong enterprise readiness with FDA clearance, HIPAA compliance, and Business Associate Agreements (BAA). However, qXR-CTR offers more flexible deployment options including cloud, on-premise, and hybrid, which caters to a wider range of enterprise IT infrastructures and security policies. This adaptability makes it more suitable for diverse healthcare organizations.
Innovation
ZEUS SystemThe ZEUS System represents a more significant innovation by combining AI-powered analysis of ECG data with long-term wearable biosensors for continuous cardiac monitoring. This approach shifts the paradigm towards proactive and personalized cardiac care for arrhythmia detection. While qXR-CTR's automation of CTR measurement is valuable, it is a more focused application compared to the transformative potential of continuous physiological monitoring.
Support & Docs
ZEUS SystemBoth companies provide comprehensive documentation, including Instructions for Use and user manuals. However, iRhythm Technologies, with its ZEUS System, also offers patient-specific support and FAQs, which is a crucial advantage given the patient-facing nature of its wearable monitoring devices. This broader scope of support resources gives Tool A a slight edge.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | ZEUS System | qXR-CTR |
|---|---|---|
| Tool Name | ZEUS System | qXR-CTR |
| Company | iRhythm Technologies | Qure.ai Technologies |
| Primary Function | AI-powered software analyzing ECG data from wearable biosensors for long-term continuous cardiac monitoring, aiding in the detection and characterization of arrhythmias like Atrial Fibrillation. | AI-powered software that automates the measurement of the cardiothoracic ratio (CTR) from chest X-ray images, aiding in the assessment of heart size and potential heart failure risk. |
| Tagline | AI-powered cardiac monitoring for early arrhythmia detection and management. | AI-powered Chest X-ray Solution for Automated Cardiothoracic Ratio Assessment. |
| Key Specialties | Cardiology, Family Medicine, Internal Medicine | Cardiology, Radiology |
Videos
Demos, reviews, and walkthroughs featuring ZEUS System and qXR-CTR.
Frequently Asked Questions
More Comparisons
More matchups featuring ZEUS System or qXR-CTR
Backers
Who funded each tool's parent company.